Mark A Feinstein

Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical development.

P. Bonaventure, Kiev S. Ly, T. Lovenberg, 2010, Bioorganic & medicinal chemistry letters.

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.

P. Bonaventure, Sandy J. Wilson, T. Lovenberg, 2009, European journal of medicinal chemistry.

2-Aryloxymethylmorpholine histamine H(3) antagonists.

P. Bonaventure, Kiev S. Ly, N. Carruthers, 2008, Bioorganic & medicinal chemistry letters.

Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model.

Patricia Andrade-Gordon, H. Almond, B. Maryanoff, 2002, Angewandte Chemie.

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.

P. Bonaventure, Sandy J. Wilson, T. Lovenberg, 2009, European journal of medicinal chemistry.

Characterization of JNJ-2482272 [4-(4-Methyl-2-(4-(Trifluoromethyl)Phenyl)Thiazole-5-yl) Pyrimidine-2-Amine] As a Strong Aryl Hydrocarbon Receptor Activator in Rat and Human

A. Bittner, N. Lim, J. W. Higgins, 2022, Drug Metabolism and Disposition.